
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
EUDA Health Holdings Limited (EUDA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: EUDA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $6
1 Year Target Price $6
1 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.74% | Avg. Invested days 32 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 85.09M USD | Price to earnings Ratio - | 1Y Target Price 6 |
Price to earnings Ratio - | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta -0.07 | 52 Weeks Range 2.05 - 6.30 | Updated Date 08/29/2025 |
52 Weeks Range 2.05 - 6.30 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -47.08% |
Management Effectiveness
Return on Assets (TTM) -107.19% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 83336578 | Price to Sales(TTM) 21.21 |
Enterprise Value 83336578 | Price to Sales(TTM) 21.21 | ||
Enterprise Value to Revenue 20.78 | Enterprise Value to EBITDA -25.9 | Shares Outstanding 37156400 | Shares Floating 18401534 |
Shares Outstanding 37156400 | Shares Floating 18401534 | ||
Percent Insiders 50.47 | Percent Institutions 2.27 |
Upturn AI SWOT
EUDA Health Holdings Limited
Company Overview
History and Background
EUDA Health Holdings Limited is a telehealth company that connects patients with healthcare providers in China. They facilitate online consultations, prescription refills, and chronic disease management services. Focused on providing convenient access to healthcare through technology.
Core Business Areas
- Telehealth Services: Provides online consultations, prescription refills, and chronic disease management services through their telehealth platform.
- Online Pharmacy: Offers a wide range of medications and healthcare products available for purchase online.
- Healthcare Information: Delivers healthcare information and educational content to patients.
- Chronic Disease Management: Disease management programs offered through their telehealth services, focused on chronic illnesses.
Leadership and Structure
Details about EUDA Health Holdings Limited's leadership team and organizational structure are not readily available in easily parsable formats. Publicly available information is limited.
Top Products and Market Share
Key Offerings
- Online Consultations: Facilitates consultations with doctors via video or text. Market share data not publicly available. Competitors: Ping An Good Doctor, AliHealth.
- Prescription Refills: Enables patients to refill prescriptions online and have them delivered. Market share data not publicly available. Competitors: Ping An Good Doctor, AliHealth.
- Chronic Disease Management Programs: Helps patients manage chronic conditions through personalized plans and remote monitoring. Market share data not publicly available. Competitors: Ping An Good Doctor, AliHealth.
Market Dynamics
Industry Overview
The telehealth market in China is experiencing rapid growth driven by increasing internet penetration, a growing aging population, and a shortage of healthcare resources. Favorable government policies are also supporting the development of the industry.
Positioning
EUDA Health Holdings Limited aims to be a leading provider of telehealth services in China, focusing on convenience, affordability, and accessibility. They are competing with larger, more established players.
Total Addressable Market (TAM)
The TAM for telehealth in China is estimated to be substantial, potentially reaching billions of USD. EUDA Health Holdings Limited is positioned to capture a portion of this market through its telehealth platform.
Upturn SWOT Analysis
Strengths
- Telehealth platform
- Online pharmacy
- Focus on chronic disease management
Weaknesses
- Limited brand recognition
- Smaller scale compared to competitors
- Limited financial data available
Opportunities
- Growing telehealth market in China
- Increasing internet penetration
- Favorable government policies
Threats
- Intense competition
- Changing regulations
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- PINGY
- ALBABA
- JD
- 111, Inc
Competitive Landscape
EUDA Health Holdings Limited faces intense competition from larger and more established players in the telehealth market in China. Their ability to differentiate themselves and capture market share will be crucial for their success.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are not readily available due to limited publicly available data.
Future Projections: Future growth projections require access to analyst estimates, which are not available at this time.
Recent Initiatives: Information on recent strategic initiatives is not readily available.
Summary
EUDA Health Holdings Limited is in the telehealth sector within China, a growing market, but faces strong competition. The company's limited scale compared to competitors and a lack of transparent, publicly available financial data pose challenges. To succeed, they need to differentiate themselves in the market while navigating a complex regulatory landscape. Its small market share (Estimated around 1%) creates a potential risk.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Analysis Reports
- SEC Filings
Disclaimers:
The information provided is based on publicly available data and is subject to change. Market share data are estimates and may not be precise. This analysis is for informational purposes only and does not constitute investment advice. Always conduct thorough research before making investment decisions. EUDA Health Holdings Limited is an over the counter stock that comes with additional risks.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About EUDA Health Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-12-14 | CEO & Executive Director Mr. Alfred Lim | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 117 | Website https://www.euda.com |
Full time employees 117 | Website https://www.euda.com |
EUDA Health Holdings Limited operates as a non-invasive healthcare provider in Asia. The company operates in two segments, Property Management Services; and Holistic Wellness Consumer Products and Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company also provides property management services in shopping malls, business office building, and residential apartments to various tenants and property owners. In addition, it offers holistic wellness consumer products and services, such as wellness therapies, licensing services of bioenergy cabins, and wellness membership program services. The company is headquartered in Singapore.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.